AIDS-related central nervous system lymphomas

Journal of Neuro-Oncology

Volumn 43, Issue 3, 1999, Pages 269-276

  Chamberlain, Marc C ^a   Kormanik, Patty A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

AIDS; CNS lymphoma

Indexed keywords

ANTINEOPLASTIC AGENT; CYTARABINE; LOMUSTINE; METHOTREXATE; PENTETATE INDIUM IN 111; PROCARBAZINE; THIOTEPA; VINCRISTINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MENINGITIS; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PALLIATIVE THERAPY; PROGNOSIS;

ADULT; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM NEOPLASMS; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HUMANS; LYMPHOMA, AIDS-RELATED; MALE; MENINGEAL NEOPLASMS; MIDDLE AGED; PREDNISONE; PROCARBAZINE; RETROSPECTIVE STUDIES; VINCRISTINE;

EID: 0032870032     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006262720665     Document Type: Article

References (39)

1. Ziegler JL, Beckstead JA, Volberding PA, Abrams DI, Levine AM, Lukes RJ: Non-Hodgkin's lymphoma in 90 homosexual men: Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome. N Engl J Med 311: 565-570, 1984
2. DeWeese TL, Hazuka MB, Hommel DJ, Kinzie JJ, Daniel WE: AIDS-related non-Hodgkin's lymphoma: The outcome and efficacy of radiation therapy. Int J Rad Onc Biol Phys 20(4): 803-808, 1991
3. Goldstein JD, Dickson DW, Moser FG, Hirschfeld AD, Freeman K, Llena JF: Primary central nervous system lymphoma in acquired immune deficiency syndrome: a clinical and pathologic study with results of treatment with radiation. Cancer 67: 8156-8165, 1991
4. Ioachim HL, Cooper MC, Hellman GC: Lymphomas in men at high risk for acquired immune deficiency syndrome (AIDS): A study of 21 cases. Cancer 56: 2831-2842, 1985
5. Knowles DM, Chamulak GA, Subar M: Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). The New York University Medical Center experience with 105 patients (1981-1986). Ann Int Med 108: 744-753, 1988
6. Louriero CL, Gill PS, Meyer PR: Autopsy findings in AIDS-related lymphoma. Cancer 62: 735-739, 1988
7. Radkin CS: Epidemiology of AIDS-related malignancies. Curr Opin Oncol 6: 492-496, 1994
8. Shibata D: Biologic aspects of AIDS-related lymphoma. Curr Opin Oncol 6: 503-507, 1994
9. Gill PS, Levine AM, Meyer PR, Boswell WD, Burkes RL, Parker JW: Primary central nervous system lymphoma in homosexual men: Clinical, immunologic and pathologic features. Am J Med 78: 742-748, 1985
10. Baumgartner JE, Rachlin JR, Beckstead JH, Meeker TC, Levy RM, Wara WM: Primary central nervous system lymphomas: Natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome. J Neurosurg 73: 206-211, 1990
11. So YT, Beckstead JH, Davis RL: Primary central nervous system lymphoma in acquired immune deficiency syndrome: A clinical and pathological study. Ann Neurol 20: 566-572, 1986
12. Formenti SC, Gill PS, Lean E, Rarick M, Meyer PR, Boswell W: Primary central nervous system lymphoma in AIDS: Results of radiation therapy. Cancer 63: 1101-1107, 1989
13. Remick SC, Diamond C, Migliozzi JA: Primary central nervous system lymphoma in patients with and without the acquired immune deficiency syndrome: A retrospective analysis and review of the literature. Medicine 69(6): 345-360, 1990
14. Forsyth PA, DeAngelis LM: Biology and management of AIDS-associated primary CNS lymphomas. Hematologic/Oncology Clinics of North America 10(5): 1125-1134, 1996
15. Chamberlain MC: Long survival in patients with AIDS-related primary CNS lymphoma. Cancer 73(6): 1728-1730, 1994
16. DeAngelis LM: Primary brain tumors in AIDS patients. Curr Opin Neural 8: 419-423, 1995
17. Forsyth PA, Yahalorn J, DeAngelis LM: Combined modality therapy in the treatment of primary central nervous system lymphoma in AIDS. Neurology 44: 1473-1478, 1994
18. Rosenblum ML, Levy RM, Bredesen DE: Primary central nervous system lymphomas in patients with AIDS. Ann Neurol 23(Suppl): S13-S16, 1988
19. Ling SM, Roach III M, Larson DA, Wara W: Radiotherapy of primary central nervous system lymphoma in patients with and without human immunodeficiency virus. Cancer 73: 2570-2582, 1994
20. Donahue BR, Sullivan JW, Cooper JS: Additional experience with empiric radiotherapy for presumed human immunodeficiency virus-associated primary central nervous system lymphoma. Cancer 76: 328-332, 1995
21. Chamberlain MC, Levin VA: Primary central nervous system lymphoma: A role for adjuvant chemotherapy. J Neuro Onc 14: 271-275, 1992
22. Hochberg FH, Loeffler JS, Prados M: The therapy of primary brain lymphoma. J Neuro Onc 10: 191-201, 1991
23. DeAngelis LM: Primary central nervous system lymphoma: A new clinical challenge. Neurology 41: 619-621, 1991
24. Chamberlain MC, Dirr L: Involved field radiotherapy and intra-ommaya methotrexate/ara-C in patients with AIDS-related lymphomatous meningitis. J Clin Onc 11: 1978-1993, 1993
25. Chamberlain MC, Sandy AD, Press GA: Leptomeningeal metastasis: A comparison of gadolinium-enhanced MR and contrast-enhanced CT of the brain. Neurol 40: 435-438, 1990
26. 111Indium-DTPA CSF flow studies. Neurol 41: 1765-1769, 1991
27. Recht L, Straus DJ, Cirrincione C: Central nervous system metastases from non-Hodgkin's lymphoma: Treatment and prophylaxis. Am J Med 84: 425-435, 1988
28. Bleyer WA, Coccia PF, Sather HN: Reduction in central nervous system leukemia with a pharmacokinetically derived intrathecal methotrexate dosage regimen. J Clin Oncol 1(5): 317-325, 1983
29. Bleyer WA, Poplack DG, Simon RM: 'Concentration × Time' methotrexate via a subcutaneous reservoir: A less toxic regimen for intraventricular chemotherapy of central nervous system neoplasms. Blood 51(5): 835-842, 1978
30. MacDonald DR, Cascino TL, Schald SC: Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8: 1277-1280, 1990
31. Blasberg RG, Patlack C, Fenstermacher JD: Intrathecal chemotherapy: Brain tissue profiles after ventriculocisternal perfusion. Pharm Exp Ther 195(1): 73-83, 1975
32. Shapiro WR, Young DF, Mehta BM: Methotrexate: Distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections. N Engl J Med 293: 161-166, 1975
33. Lopex JA, Nassif E, Vannicola P: Central nervous system pharmacokinetics of high-dose cytosine arabinoside. J Neuro-Oncol 3: 119-124, 1985
34. Ackland SP, Schilsky RL: High-dose methotrexate: A critical reappraisal (review article). J Clin Oncol 5: 2017-2031, 1987
35. Giannone L, Greco FA, Hainsworth JD: Combination intra-ventricular chemotherapy for meningeal neoplasia. J Clin Oncol 4: 68-73, 1986
36. Hitchens RN, Bell DR, Woods RL, Levi JA: A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis. J Clin Oncol 5: 1655-1662, 1987
37. DeAngelis LM, Yahalorn J, Thaler HT: Combined modality therapy for primary CNS lymphoma. J Clin Oncol 10: 635-643, 1992
38. Mathews C, Barba D, Fullerton SC: Early biopsy versus treatment with delayed biopsy of non-responders in suspected HIV-associated cerebral toxoplasmosis: A decision analysis. AIDS 9: 1243-1250, 1995
39. Peterson K, Gordon KB, Heinemann M-H, DeAngelis LM: The clinical spectrum of ocular lymphoma. Cancer 72: 843-849, 1993